LOS ANGELES, United States: QY Research has recently published a research report titled, Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2021-2027. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Induced Pluripotent Stem Cells (iPSCs) market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Induced Pluripotent Stem Cells (iPSCs) market.
The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Induced Pluripotent Stem Cells (iPSCs) market.
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Induced Pluripotent Stem Cells (iPSCs) market.
Key questions answered in the report:
TOC
1 Report Overview1.1 Study Scope1.2 Market Analysis by Type1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2016 VS 2021 VS 20271.2.2 Human iPSCs1.2.3 Mouse iPSCs1.3 Market by Application1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2016 VS 2021 VS 20271.3.2 Academic Research1.3.3 Drug Development and Discovery1.3.4 Toxicity Screening1.3.5 Regenerative Medicine1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2016-2027)2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2016 VS 2021 VS 20272.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Share by Regions (2016-2021)2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2022-2027)2.3 Induced Pluripotent Stem Cells (iPSCs) Industry Dynamic2.3.1 Induced Pluripotent Stem Cells (iPSCs) Market Trends2.3.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers2.3.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges2.3.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints 3 Competition Landscape by Key Players3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2016-2021)3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2016-2021)3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue3.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio3.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 20203.5 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served3.6 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service3.7 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market3.8 Mergers & Acquisitions, Expansion Plans 4 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2016-2021)4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2022-2027) 5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application5.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2016-2021)5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2022-2027) 6 North America6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)6.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type6.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)6.2.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)6.2.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application6.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)6.3.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)6.3.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country6.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)6.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)6.4.3 United States6.4.3 Canada 7 Europe7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type7.2.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)7.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)7.2.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application7.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)7.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)7.3.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country7.4.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)7.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)7.4.3 Germany7.4.4 France7.4.5 U.K.7.4.6 Italy7.4.7 Russia7.4.8 Nordic 8 Asia-Pacific8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type8.2.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)8.2.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)8.2.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application8.3.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)8.3.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)8.3.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)8.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region8.4.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021)8.4.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2022-2027)8.4.3 China8.4.4 Japan8.4.5 South Korea8.4.6 Southeast Asia8.4.7 India8.4.8 Australia 9 Latin America9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)9.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type9.2.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)9.2.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)9.2.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)9.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application9.3.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)9.3.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)9.3.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)9.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country9.4.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)9.4.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)9.4.3 Mexico9.4.4 Brazil 10 Middle East & Africa10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2016-2027)10.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type10.2.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)10.2.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2022-2027)10.2.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2027)10.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application10.3.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)10.3.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2022-2027)10.3.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2027)10.4 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country10.4.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)10.4.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2022-2027)10.4.3 Turkey10.4.4 Saudi Arabia10.4.5 UAE 11 Key Players Profiles11.1 Fujifilm Holding Corporation (CDI)11.1.1 Fujifilm Holding Corporation (CDI) Company Details11.1.2 Fujifilm Holding Corporation (CDI) Business Overview11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.1.5 Fujifilm Holding Corporation (CDI) Recent Development11.2 Ncardia11.2.1 Ncardia Company Details11.2.2 Ncardia Business Overview11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction11.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.2.5 Ncardia Recent Development11.3 Sumitomo Dainippon Pharma11.3.1 Sumitomo Dainippon Pharma Company Details11.3.2 Sumitomo Dainippon Pharma Business Overview11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction11.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.3.5 Sumitomo Dainippon Pharma Recent Development11.4 Astellas Pharma Inc11.4.1 Astellas Pharma Inc Company Details11.4.2 Astellas Pharma Inc Business Overview11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction11.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.4.5 Astellas Pharma Inc Recent Development11.5 Fate Therapeutics, Inc11.5.1 Fate Therapeutics, Inc Company Details11.5.2 Fate Therapeutics, Inc Business Overview11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction11.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.5.5 Fate Therapeutics, Inc Recent Development11.6 Pluricell Biotech11.6.1 Pluricell Biotech Company Details11.6.2 Pluricell Biotech Business Overview11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction11.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.6.5 Pluricell Biotech Recent Development11.7 Cell Inspire Biotechnology11.7.1 Cell Inspire Biotechnology Company Details11.7.2 Cell Inspire Biotechnology Business Overview11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction11.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.7.5 Cell Inspire Biotechnology Recent Development11.8 ReproCELL11.8.1 ReproCELL Company Details11.8.2 ReproCELL Business Overview11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction11.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2016-2021)11.8.5 ReproCELL Recent Development 12 Analysts Viewpoints/Conclusions 13 Appendix13.1 Research Methodology13.1.1 Methodology/Research Approach13.1.2 Data Source13.2 Disclaimer13.3 Author Details
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
See original here:
- Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks - Nature.com - March 28th, 2024
- Synthetic Circuits Reveal the Key to Rewinding the Cellular Clock - The Scientist - March 13th, 2024
- synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy - Nature.com - March 3rd, 2024
- Breaking through new research barriers with iPSC technology - News-Medical.Net - February 15th, 2024
- Abu Dhabi Stem Cells Centre partners with Rege Nephro and Kyoto University's Center for iPS Cell Research and ... - Abu Dhabi Media Office - January 12th, 2024
- Abu Dhabi Stem Cells Center partners with Japan-based Kyoto University and Rege Nephro - ZAWYA - January 12th, 2024
- Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for ... - Nature.com - December 23rd, 2023
- Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming - Nature.com - December 15th, 2023
- Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform - PR Newswire - December 13th, 2023
- CRISPRi gene modulation and all-optical electrophysiology in post-differentiated human iPSC-cardiomyocytes ... - Nature.com - December 7th, 2023
- World Hindu Congress 2023: Know all about the sessions and speakers - Organiser - November 23rd, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS ... - Business Wire - November 21st, 2023
- Efficient protocol for the differentiation of kidney podocytes from ... - Nature.com - November 17th, 2023
- Vitamin B12 is a limiting factor for induced cellular plasticity and ... - Nature.com - November 17th, 2023
- Study reveals the critical role of microglia in human brain development - Medical Xpress - November 15th, 2023
- VCCT Inc., Leading the Field of Retinal Regeneration through iPS Cells, Raises 600 million Japanese yen (approximately $4 million USD) through... - November 15th, 2023
- Who are the leading innovators in iPSCs for the pharmaceutical ... - Pharmaceutical Technology - November 7th, 2023
- Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous... - November 5th, 2023
- Systematic differences in discovery of genetic effects on gene ... - Nature.com - October 21st, 2023
- Pairwise biosynthesis of ion channels stabilizes excitability and ... - pnas.org - October 11th, 2023
- Scientists find multitude of genes associated with autism - The Statesman - October 9th, 2023
- Stem Cell Banking Market is Expected to Reach USD 16,474.30 ... - Digital Journal - October 7th, 2023
- Probing the individuality of cells and molecules - Open Access Government - October 5th, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Manchestertimes - October 3rd, 2023
- Thymmune Therapeutics Receives $37M in Funding from the ... - Business Wire - September 29th, 2023
- Less Funding to More Researchers Gets Nobel-level Results, Study ... - The Japan News - September 27th, 2023
- Brentuximab Vedotin Plus AVD Gets Positive CHMP Opinion for ... - OncLive - September 20th, 2023
- DKMS BMST Foundation India and Kokilaben Hospital unite to spread awareness about the Importance of Stem Cell Donation on World Marrow Donor Day - APN... - September 18th, 2023
- Vitamin B6 is governed by the local compartmentalization of ... - Science - September 14th, 2023
- Dolly the sheep creator Ian Wilmut dies aged 79 - BBC - September 14th, 2023
- Scientist who created Dolly the sheep dies aged 79: Professor Sir Ian Wilmut passes away five years after reve - Daily Mail - September 11th, 2023
- The global kits market is expected to grow at a CAGR of 7.4% from ... - Digital Journal - September 8th, 2023
- Eterna Therapeutics Announces Initiation of Development Activities ... - PipelineReview.com - September 8th, 2023
- Tokyo: 100 Years of Urban Regeneration / Tokyo's Nihonbashi Area ... - The Japan News - August 31st, 2023
- Transcriptome-based prediction of drugs, inhibiting ... - Nature.com - August 30th, 2023
- From the birds and the bees to IVG - The Gauntlet - August 26th, 2023
- Breakthrough creates stem cells without any memories - Freethink - August 26th, 2023
- Aging impairs the neurovascular interface in the heart - Science - August 26th, 2023
- For This Venture Capitalist, Research on Aging Is Personal; 'Bob ... - The Wall Street Journal - August 22nd, 2023
- Unleashing Potential: Illuminating the Future of Healthcare through Revolutionary Induced Pluripotent Stem Cel - openPR - August 18th, 2023
- A 'memory wipe' for stem cells may be the key to better therapies - The Conversation - August 16th, 2023
- Erasing epigenetic 'memory' to improve the quality of stem cells - FierceBiotech - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Business Wire - August 16th, 2023
- HebeCell and Logomix Announce Collaboration for the ... - Valdosta Daily Times - August 11th, 2023
- Advancing Clinical Trials with iPSC-Derived Liver Organoids - Microbioz India - August 11th, 2023
- Activation of cAMP (EPAC2) signaling pathway promotes hepatocyte ... - Nature.com - August 1st, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of Aging Damage Reversal Showing GIVI-MPC Stem Cell Therapys Ability to Create New Skeletal... - July 30th, 2023
- Femtech in Japan: An Industry on the Rise - Femtech Insider - July 28th, 2023
- Association between enhanced carbonyl stress and decreased ... - Nature.com - July 28th, 2023
- Defects in early synaptic formation and neuronal function in Prader ... - Nature.com - July 27th, 2023
- IPS HEART Announces Peer-Reviewed Publication in Cells of ... - Business Wire - July 25th, 2023
- Cure to Autism and Alzheimer's May Be in Space, Says 1st Brazilian Scientist who Will Be on The ISS - Folha de S.Paulo - July 25th, 2023
- Futurama's Resurrection Ruins The Perfect Ending (& Shows Must ... - Looper - July 25th, 2023
- University Of Massachusetts Amherst's Team Bags Honour Of 2023 Armstrong Fund For Science Award - India Education Diary - July 20th, 2023
- Scientists working on IVG, a new reproductive method that can make human babies in labs - IndiaTimes - July 19th, 2023
- Co-transplantation of autologous Treg cells in a cell therapy for ... - Nature.com - July 13th, 2023
- Magic Valley and Biocellion Join Forces to Improve Bioreactor Tech ... - vegconomist - the vegan business magazine - July 13th, 2023
- IPS HEART Receives U.S. FDA Rare Pediatric Drug Designation for ... - Tullahoma News and Guardian - July 10th, 2023
- Hitachi : forms strategic research collaboration with Mass General Brigham in the field of regenerative medicine and GCT - Marketscreener.com - July 6th, 2023
- Cell therapy limitations with iPS-based multi-cell therapeutics - Drug Target Review - July 6th, 2023
- Remembering Dolly- The Clone Sheep On Her Birth Anniversary - Free Press Journal - July 4th, 2023
- Labs and Translational Research - UMass Medical School - June 28th, 2023
- Cellusion raises 2.83B series C round to progress iPS cell-derived ... - BioWorld Online - June 14th, 2023
- Japan-based Fujifilm introduces first-of-its-kind human iPSC-derived ... - BSA bureau - June 6th, 2023
- ALS: Parkinson's drug ropinirole may be an effective treatment - Medical News Today - June 4th, 2023
- Scientists predict lab-grown babies in five years - Kidspot - June 4th, 2023
- Lab-grown babies could become a reality within five years - Earth.com - May 26th, 2023
- Leading healthcare experts from MENA and beyond to explore the future of precision medicine in the region at PMES 23 this month - ZAWYA - May 24th, 2023
- Long-Awaited Ax-2 Mission Launches, Heads to Space Station - AmericaSpace - May 22nd, 2023
- Eterna Therapeutics and Factor Bioscience Announce New Data on ... - GlobeNewswire - May 17th, 2023
- Research Assistant job with UNITED ARAB EMIRATES ... - Times Higher Education - May 10th, 2023
- Regulation of synaptic connectivity in schizophrenia spectrum by ... - Nature.com - April 29th, 2023
- Researchers Discover Key Role of Glucose in Brain Activity - Laboratory Equipment - April 25th, 2023
- Structure of Huntington's Protein Revealed - Technology Networks - April 21st, 2023
- Study of brain immune cell infection may explain long COVID ... - NHK WORLD - April 19th, 2023
- The Mechanism That Regulates Activity of Memory Gene - Neuroscience News - April 19th, 2023
- The IPO Buzz: CytoMed Therapeutics Prices its Micro-Cap IPO at ... - IPOScoop - April 19th, 2023
- Macomics Presents its ENIGMAC Discovery Platform for Gene to Function Target Validation of Novel Macrophage Therapies at AACR - Yahoo Finance - April 19th, 2023
- Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ... - Nature.com - April 19th, 2023
- A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves ... - pnas.org - April 16th, 2023
Recent Comments